Uzm. Dr. Hakan Öztürk

  • Uzmanlık Alanları: Laparoskopik üroloji, Çocuk ürolojisi, Kadın ürolojisi, Ürolojik Onkoloji, Laparoskopik Kanser Cerrahisi, Lazer Prostat Cerrahisi, Greenlight
Eğitim ve Uzmanlık
Uludağ Üniversitesi Tıp Fakültesi - Tıp Eğitimi
İzmir Atatürk Eğitim ve Araştırma Hastanesi - Uzmanlık
Şifa Üniversitesi Hastanesi - Uzmanlık
 
Mesleki Üyelikler
Avrupa Üroloji Derneği
Türk üroloji Derneği
Türk Androloji Derneği
Endoüroloji Derneği
Ege Üroloji Derneği
İzmir Tabip Odası

Sertifikalar ve Kurslar
Live Surgery Workshop on Holmium Lazer Enucleation of the Prostate, HoLEP, Aguste Victoria Hospital, Sertifika, 07.04.2017 -08.04.2017 (Uluslararası)
Ulusal Üroloji ve 26. Dünya Videoüroloji Kongresi, Genel Üroloji, Swissotel Grand Efes, Sertifika,
20.10.2015 -24.10.2015 (Uluslararası)
4th World Congress on Cancer Science & Therapy, Onkoloji, DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, Sertifika, 20.10.2014 -22.10.2014 (Uluslararası)
Urostars: Minimal Invaziv Üroonkoloji ve Endoüroloji, Laparoskopik Üroloji, Cemic University, Sertifika, 24.09.2014 -28.09.2014 (Uluslararası)
Büyük Üroloji Bulusması, Genel Üroloji, Marıtım Pine Beach Kongre Merkezi, Sertifika, 31.10.2013 - 03.11.2013 (Ulusal)

Metastatik Hormona Duyarlı Prostat Kanserli (mHSPC) Gönüllülerde Androjen Deprivasyon Tedavisi (ADT) Karsısında Apalutamid ile ADT Kombinasyon Tedavisinin Arastırıldıgı Randomize, Plasebo Kontrollü, Çift Kör Faz 3 Çalısma”, Diger (Uluslararası), Arastırmacı, , 21/02/2016
Yüksek Riskli Lokalize veya Lokal Olarak Ilerlemis Prostat Kanseri Olup Primer Radyasyon Terapisi ileTedavi Almakta Olan Hastalarda JNJ-56021927’nin Arastırıldıgı Randomize, Çift Kör, Plasebo Kontrollü Faz 3 Çalısma. ( ATLAS Çalısması protokol: 56021927PCR3003), Diger (Uluslararası), Basım Tarihi : 26/04/2017 22:30:47 Sayfa: 5 Arastırmacı, , 11/07/2016
Tedavi Edilmemis Lokal Ileri Veya Metastatik Ürotelyal Karsinomlu Hastalarda Monoterapi Olarak Veya Platin Bazli Kemoterapi Ile Kombinasyon Halinde Atezolizumab (Antipd-L1 Antikoru)ın Arastırıldıgı Faz III, Çok Merkezli, Randomize, Plasebo Kontrollü Çalısma,WO30070", Diger (Uluslararası), Arastırmacı, , 01/12/2016
Ileri evre Ürotelyal Karsinomda Kemoterapiye Kıyasla Kemoterapi ile Birlikte veya Tek Basına Pembrolizumabın Degerlendirildigi Faz III, Randomize, Kontrollü Çalısma KEYNOTE-361, Diger (Uluslararası), Arastırmacı, , 05/04/2017
 

 

1-Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724. Epub 2015 Jan 16.
2-Öztürk H. Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer Res Treat. 2015 Feb 12. doi: 10.4143/crt.2014.157. [Epub ahead of print]
3-Öztürk H. Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy using plasma-button vaporization. Scand J Urol. 2015 Feb 19:1-6. [Epub ahead of print]
4-Saracoglu M, Öztürk H, Duran A , Atalay S. Effect of microorganisms on etiology of hematospermia. Arch Ital Urol Androl. 2015 Mar 31;87(1):80-2.
5-Öztürk H. High-grade Primary Renal Leiomyosarcoma. Int Braz J Urol. 2015 Mar-Apr;41(2):304-311.
6-Öztürk H. Diagnostic role of 18f-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma. Minerva Urol Nefrol. 2015 Apr 28. [Epub ahead of print]
7-Öztürk H. Tubeless versus standard PCNL in geriatric population. Actas Urol Esp. 2015 Apr 30. pii: S0210-4806(15)00119-9. doi: 10.1016/j.acuro.2015.02.010. [Epub ahead of print]
8-Saraçoglu M, Öztürk H,Duran A,Atalay S. The Microorganisms Isolated From Urine And Ejaculate Samples And The Antibiotic Susceptibilities – Kasmera, 43(1), 155-163.
9-Öztürk H. Comparing RECIST with EORTC Criteria in Metastatic Bladder Cancer J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94. doi: 10.1007/s00432-015-2022-2. Epub 2015 Jul 25.
10-Saracoglu M, Öztürk H, Duran A , Atalay S. The Relationship Between Coronal Sulcus Lymphangitis And IgE Rev Int Androl. 2016;14(1):8-12. doi:10.1016/j.androl.2015.07.006
11-Karaarslan S, Yaman B, Öztürk H, Kumbaraci BS. Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters. J Pathol Transl Med. 2015 Sep;49(5):389-95. doi: 10.4132/jptm.2015.08.10. Epub 2015 Sep 16.
12-Öztürk H, Karapolat I. 18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer. Oncol Lett. 2016 Jan;11(1):316-322. Epub 2015 Nov 10.
13-Öztürk H. Penile Mondor's Disease. Basic and Clinical Andrology 2014, 24:5 doi:10.1186/2051-4190-24-5.
14-Saraçoglu M, Öztürk H. Female Circumcision. Andrology & Gynecology: Current Research 2014, 2:2 http://dx.doi.org/10.4172/2327-4360.1000120
15-Öztürk H. Gastrointestinal System Complications in Percutaneous Nephrolithotomy: A Systematic Review. . J Endourol. 2014 Nov;28(11):1256-67. doi: 10.1089/end.2014.0344. Epub 2014 Sep 5.
16-Öztürk H. Elective Urological Surgery Following Coronary Stent Implantation To Whom, How To Do it?. Curr Urol. 2014 Oct;7(4):169-73. doi: 10.1159/000365670. Epub 2014 Aug 20. Review.
17-Saraçoğlu M, Öztürk H, Zengin T, Gümüş B. Erkeklerde genital pirsing. Androloji bülteni 2014; Ara (59): 222-226.
18-Saracoglu M, Zengin T, Öztürk H, Genc M. Female Genital Mutilation/Cutting Type 4. J Androl Gynaecol. 2014 Dec;2(4): 5.
19-Öztürk H. Prognostic features of renal sarcomas (Review). Oncol Lett. 2015 Mar;9(3):1034-1038. Epub 2014 Dec 30.
20-Öztürk H, Saraçoglu M, Karaarslan S, Zengin T, Gülşen A, Kalaycıoğlu S. A case of renal tuberculosis diagnosed during percutaneous nephrolithotomy. Case Reports in Clinical Medicine 2013 Vol.2, No.7, 411-414 http://dx.doi.org/10.4236/crcm.2013.27109
21-Öztürk H, Sivrikoz ON. High-Grade Primary Spindle Cell Sarcoma of the Prostate: A Case Report and Review of the Literature. World J Oncol. 2013;4(6):258-261.
22-Öztürk H, Karaaslan S. High-Grade Primary Leiomyosarcoma of the Kidney. World J Nephrol Urol. 2014;3(1):63-65 doi: http://dx.doi.org/10.14740/wjnu158e
23-Öztürk H. Adrenal Ganglioneuroma Presenting As Left Renal Mass. World J Oncol. 2014;5(2):90-92. doi: http://dx.doi.org/10.14740/wjon783w
24-Öztürk H. Renal Mucinous Tubular and Spindle Cell Carcinoma and (18)F-Fluorodeoxyglucose-PET/CT Findings. Clin Genitourin Cancer. 2014 Aug;12(4):e161-6. doi: 10.1016/j.clgc.2014.03.011. Epub 2014 Apr 2.
25-Öztürk H. Vena Cava Invasion By Adrenal leiomyosarcoma. Rare tumors 2014 Jun 23;6(2):5275,55-6.
26-Öztürk H. Intrarenal Pseudoaneurysm After Percutaneous Nephrolithotomy at Solitary Kidney. Nephro Urol Mon. 2014 Sep; 6(5): e19037.
27-Öztürk H, Karaaslan S. Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5271-9.
28-Öztürk H, Karaaslan S. Metachronous Adrenal Metastasis From Operated Contralateral Renal Cell Carcinoma With Adrenalectomy And Iatrojenic Addison Disease. Can Urol Assoc J 2014;8(9-10):e744-8.
29-Öztürk H, Multiple Carsinosarcomas Of The Kidney: A case report and review of the literature. Molecular and Clinical Oncology 2015 Jan (3): 212-216.
30-Öztürk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Jun 11;82(2):114-7. doi: 10.5301/uro.5000094. Epub 2014 Nov 25.
31-Öztürk H. 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney. Indian J Nucl Med 2015 Jan-Mar;30(1):68-71.
32-Öztürk H. Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings. Urol Ann. 2015 Jan;7(1):115-19.
33-Öztürk H. Peripheral neuroectodermal tumour of the kidney (Ewing’s sarcoma): Restaging with 18F-fluorodeoxyglucose (FDG)-PET/CT. Can Urol Assoc J 2015 Jan-Feb;9(1-2):E39-44.
34-Öztürk H. Penile mucinous carcinoma: A case report. Oncol Lett. 2015 Mar;9(3):1293-1296. Epub 2014 Dec 30.
35-Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol Lett. 2015 Apr;9(4):1897-1901. Epub 2015 Jan 28.
36-Öztürk H. Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT. Int J Surg Case Rep. 2015 Apr 14;11:33-36. doi: 10.1016/j.ijscr.2015.04.017. [Epub ahead of print]
37-Öztürk H. Penile Mondor's disease; diagnosis with magnetic resonance imaging. Revista Internacional de Andrologia; Jul-Sep. 2015;13(3):104-108.
38-Öztürk H. Treatment of Colonic Injury During Percutaneous Nephrolithotomy. Rev Urol. 2015;17(3):194-201.
39-Öztürk H. Facilitate Stent Removal: Magnetic DJ Stent. Urol Case Rep. 2017 Feb 2;11:55-56. doi: 10.1016/j.eucr.2016.11.021. eCollection 2017 Feb.
40-Öztürk H. Re: Wong et al.: Is Percutaneous Nephrolithotomy in Solitary Kidneys Safe? (Urology 2013;82:1013-1016). Urology. 2014 Apr;83(4):959. doi: 10.1016/j.urology.2013.12.058.
41-Öztürk H. How real is the uterine transplantation? Ann Transplant. 2014 Feb 14;19:82-3. doi: 10.12659/AOT.889973.
42-Öztürk H, Saracoglu M, Zengin T, Sivrikoz ON, Kerman HS, Adakan S. Asymptomatic Sertoli cell tumour diagnosed during azoospermia work-up. Asian J Androl. 2013 Nov;15(6):845-6. doi: 10.1038/aja.2013.101. Epub 2013 Oct 14.
43-Öztürk H. Neurologic complications of percutaneus nephrolithotomy. Int Neurourol J. 2014 Mar;18(1):45-7. doi: 10.5213/inj.2014.18.1.45. Epub 2014 Mar 31.
44-Öztürk H. Wireless Capsule Cystoscopy: How Near? How Far?. Open Journal of Urology, 2014, 4, 37-40. http://dx.doi.org/10.4236/oju.2014.44007
45-Öztürk H. Re: Parikh GP, Sonde SR, Kadam P. Venous air embolism: A complication during percutaneous nephrolithotomy. Indian J Urol 2014;30(4):456-7.
46-Öztürk H. Genetic architecture of renal cell carcinoma: Do we have to know? World J Urol. 2016 Jun;34(6):765-9. doi: 10.1007/s00345-015-1697-y.
47-Öztürk H. How do PDE5 Inhibutors close to solution at the treatment of BPH? J Clin Pharmacol. 2016 Apr;56(4):381-2. doi: 10.1002/jcph.623. Epub 2015 Oct 20.
48-Öztürk H. Evaluation of Bosniak Type IIF and III Renal Cysts with Contrast-enhanced Ultrasound. Journal of the Belgian Society of Radiology, 100(1): 12, pp. 1–2, 2016. DOI: http://dx.doi.org/10.5334/jbr-btr.843
49-Öztürk H. Mitochondria Transplantation: Why?, J Reprod Med. 2016 Mar-Apr;61(3-4):182-4.
 
Ulusal Yayınları
Solak A, Öztürk H, Sahin N,Saraçoğlu M,Kalaycıoğlu S,Genç B (2013). Mesane çıkısı obstrüksiyonunun non invaziv tanısında intravezikal prostatik protüzyonun önemi Semptomlar ve üroflovmetrik sonuçlarla korelasyon. Yeni Tıp Dergisi(30), 220-223.
Öztürk H (2013). Prostat Kanseri Tedavisinin Gelecegi Apopitoz mu. The Cystoscope, 1(1),6-9.
Zengin T,Saraçoğlu M,Karaarslan S, Öztürk H (2013). Spermatik Kordda Adrenal Ektopik Doku ve Testisde Spermatositik SeminomBirlikteligi Literatüre Kısa Bakıs. The Cystoscope, 1(1), 55-57.
Öztürk H,Saraçoğlu M,Zengin T,Kerman HS (2013). Benign Prostat Hiperplazisi ve Asırı Aktif Mesane BirlikteligineGüncel Bakıs. Türkiye Klinikleri Uroloji, Dergisi, 4(2), 82-87., Doi: 1309-632X.
Saraçoğlu M, Öztürk H, Zengin T (2014). Ürodinamik Çalısmaların Tedavinin Yönlendirilmesine Katkısı Nedir?. The Cystoscope , 1(3), 189-195.
Öztürk H,,Gümüş BH (2014). Metabolik sendrom ve kadınlarda seksüel disfonksiyon. Androloji Bülteni, 16(56), 77-82.
Öztürk H, (2014). Geriatrik Popülasyonda Alfa-Bloker ve Antikolinerjik Kullanımının Sistemik Etkileri.. Akademik Geriatri Dergisi, 6(2), 62-72.
Saraçoğlu M, Öztürk H, Zengin T,Gümüş BH (2014). Erkeklerde genital pirsing. Androloji Bülteni, 16(59), 222-226.
Üşar P,Kar AA,Maral J,Yalaz S, Öztürk H, (2014). Genel Anestezi Sonrası Gelisen Negatif Basınç Akciger Ödemi. Journal of Anesthesia - JARSS, 22(2), 116- 19.
Yalçın M, Saklamaz A, Doğan F, Öztürk H,Aykır H,Yılmaz H (2015). Ciddi Hipolaksemi Gelisen Yaygın Osteoblastik Kemik Metastazlı Prostat Kanserli Bir Hasta.. Ege Klinikleri Tıp Dergisi, 53(1), 144-148.
Öztürk H, (2017). Evaluation of Response to Therapy Using 18FDG-PET/CT Before and AfterGemcitabine plus Cisplatin-Based Chemotherapy for Metastatic Bladder Cancer. Uluslararası Hematoloji Onkoloji Dergisi.z